Mineralcorticoid receptor antagonist for producing drug for permanent treatment of endometriosis, comprises spironolactone, eplerenone and drospirenone

MOELLER CARSTEN, KAUFMANN-REICHE ULRIKE, SCHMIDT ANJA, FUHRMANN ULRIKE
2008
OA: closed Metadata only

Abstract

The mineralcorticoid receptor antagonist comprises spironolactone, eplerenone and drospirenone. Glucocorticoid, progesterone receptor antagonist and estrogen receptor antagonist are also included. The estrogen is ethinylestradiol. - ACTIVITY : Gynecological. - MECHANISM OF ACTION : Mineralcorticoid receptor antagonist Gonadotropin-releasing hormone (GnRH) agonist.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-06T06:10:23.601157+00:00